OR WAIT null SECS
July 30, 2019
Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.
June 13, 2019
The companies will form a biometrics organization focused on delivering analytical solutions for drug development.
The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.
May 07, 2019
The acquisition is expected to strengthen SGS’s agriculture, food, and life business in the United States.
April 30, 2019
Lonza’s SimpliFiH Services addresses bioavailability challenges with drug substance, solid-state characterization, and drug product for first-in-human studies.
April 23, 2019
Cambrex’s expanded quality control laboratory supports generic API development.
April 16, 2019
The companies will merge to offer a broader range of analytical data packages and regulatory support for biopharmaceuticals.
April 02, 2019
The partnership will enable the Applied Process Company (APC) and the National Institute for Bioprocessing Research & Training (NIBRT) to provide increased access to R&D and analytical services.
Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.
March 18, 2019
The expansion includes a new R&D laboratory and the installation of a 12,000-liter reactor at one of the company’s manufacturing facilities on its Paullo site in Milan, Italy.